Carregando empresa
Just reported
Q3 2026 results
From Waters's results release of 3 de novembro de 2026; its quarterly report has since been filed.
Revenue
Actual
US$ 1,77B
+121% y/y
+7,4% q/qGuided
US$ 858,5M
midpoint
Above guide+106%EPS, GAAP
Actual
US$ 0,82
-67% y/y
Guided
—
No guide given
Operating income, GAAP
Actual
US$ 128M
-33% y/y
Guided
—
No guide given
Company outlook
Full year 2026
- RevenueUS$ 3,429B+8,3% y/y Raised +1,8%
- EPS, adjustedUS$ 14,60 – US$ 14,70Raised +1,4%
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Waters is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Diagnostics and Research
Graded A or B and worth $2B or more: A first, then the largest.
TMOThermo Fisher Scientific Inc.US$ 259,2BA+
IDXXIdexx Laboratories Inc.US$ 55BA+
IQVIQVIA Holdings Inc.US$ 44,7BA
ILMNIllumina, Inc.US$ 31,7BA+
LHLabcorp Holdings Inc.US$ 30,2BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 de out. de 2026CBGraded C, now B
MCKMckesson Corporation4 de nov. de 2026BAGraded B, now A
CVSCVS Health Corp4 de nov. de 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 de nov. de 2026BAGraded B, now A
BIIBBiogen Inc.28 de out. de 2026BAGraded B, now A
Demonstrações financeiras completas →
Construído a partir dos próprios documentos de Waters Corporation entregues à Comissão de Valores Mobiliários dos EUA (SEC). Os números são os divulgados, com o histórico por ação recalculado para a base de ações de hoje. Isto descreve um negócio — não é recomendação de investimento nem sugestão de compra ou venda.